Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4
Authors:
- Claire HivrozCHClaire Hivroz
- Jean Claude BrouetJBJean Claude Brouet
- Catherine Grillot‐CourvalinCGCatherine Grillot‐Courvalin
- 1 June 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (6) , 1025-1030
Abstract
Recombinant interleukin (IL) 4 has been shown to be able to up‐regulate low‐affinity Fc receptor for IgE (FcεRII)‐CD23 expression on B cells as well as on other human mononuclear cells. We demonstrate here that, in opposition with previous reports, recombinant IL 2 also can up‐regulate CD23 expression on B cells. This was first observed on CLL cells which represent a monoclonal proliferation of B cells arrested at an intermediate stage of activation. Cells of 5 out of 12 B‐CLL studied display such an increase and all 5 proliferated, in vitro, directly in response to IL 2. Similarly, upon triggering with anti‐μ and IL 2, normal tonsillar B lymphocytes also demonstrate an increase of CD23 expression but this was observed only on day 3. Interferon‐γ was able to inhibit this IL 2‐mediated up‐regulation of CD23 on normal B cells but not on CLL‐B cells; on those cells interferon‐γ was similarly unable to inhibit the IL 4‐mediated CD23 up‐regulation. These results suggest that CD23 regulation is complex and related to the stage of activation and the cell type.Keywords
This publication has 21 references indexed in Scilit:
- Two species of human Fcε receptor II ( ): Tissue-specific and IL-4-specific regulation of gene expressionCell, 1988
- Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.Journal of Experimental Medicine, 1988
- Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activationBritish Journal of Haematology, 1988
- Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)European Journal of Immunology, 1988
- Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE‐binding factor analogous to that spontaneously released by lymphoblastoid B cell linesEuropean Journal of Immunology, 1988
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.Journal of Experimental Medicine, 1987
- Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching.Journal of Experimental Medicine, 1986
- From parasites to allergy: a second receptor for IgEImmunology Today, 1986
- Ligation of the CD23, p45 (BLAST‐2, EBVCS) antigen triggers the cell‐cycle progression of activated B lymphocytesEuropean Journal of Immunology, 1986
- Interleukin 2-induced proliferation of leukemic human B cells.Journal of Experimental Medicine, 1985